SCHEMBL22105439

SCHEMBL22105439

CCC(C)N1c2ncn(Cc3ccccc3)c2C(=O)NC1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.42
▸ TSHR P16473 2/20 0.42
▸ GDA Q9Y2T3 1/20 0.40
▸ HPGD P15428 1/20 0.39
▸ CYP11B2 P19099 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ ADORA2B P29275 1/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.37
▸ GAA P10253 2/20 0.36
▸ PARN O95453 1/20 0.36
▸ CNOT7 Q9UIV1 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ TNF P01375 1/20 0.36
▸ CYP11B1 P15538 1/20 0.36
▸ PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22105567 0.82 TSHR (0.45) ALDH1A1TSHRGDACYP11B2SMN1; SMN2
SCHEMBL21499645 0.70 GDA (0.46) ALDH1A1TSHRGDAHPGDCYP11B2
SCHEMBL23974592 0.67 TSHR (0.57) ALDH1A1TSHRGDAHPGDCYP11B2
SCHEMBL22105440 0.63 BRD4 (0.62) ALDH1A1HPGDSMN1; SMN2ADORA2BRXFP1
SCHEMBL16068380 0.61 CYP11B2 (0.54) ALDH1A1TSHRGDACYP11B2SMN1; SMN2
SCHEMBL5745154 0.60 GDA (0.51) ALDH1A1TSHRGDAHPGDCYP11B2
SCHEMBL7985407 0.58 CNOT7 (0.54) ALDH1A1HPGDSMN1; SMN2ADORA2BRXFP1
SCHEMBL5341956 0.58 SMN1; SMN2 (0.50) ALDH1A1TSHRHPGDCYP11B2SMN1; SMN2
SCHEMBL21499649 0.58 MAPK1 (0.43) ALDH1A1TSHRCYP11B2SMN1; SMN2CYP1A2
SCHEMBL30595217 0.57 PARN (0.54) TSHRHPGDCYP11B2SMN1; SMN2ADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11198696-B2 Substituted xanthines as inhibitors of transient receptor potential cation channel subfamily c, member 5 activity BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2021-12-14 — — US disclosed
US-20200190093-A1 SUBSTITUTED XANTHINE DERIVATIVES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2020-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200190093-A1 SUBSTITUTED XANTHINE DERIVATIVES TRPC5, TRPC4, TRPM5 ALDH1A1 869/4885TSHR 1665/4885GDA 2668/4885
US-11198696-B2 Substituted xanthines as inhibitors of transient receptor potential cation channel subfamily c, member 5 activity TRPC5, TRPM5, TRPC4 ALDH1A1 1568/4885TSHR 1011/4885GDA 2588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback